Missing/wrong data? Edit Wikidata item
Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?
scientific article published on 17 November 2020
Author/s
Work details
Publication date:
November 17, 2020
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.